Where it is registered
Each register with its number of medicines and a few of them.
Croatia
HALMED · 4 medicines
- Imipenem/cilastatin AptaPharma 500 mg/500 mg prašak za otopinu za infuzijuprašak za otopinu za infuziju · Apta Medica Internacional d.o.o., Likozarjeva ulica 6, Ljubljana, Slovenija
- Imipenem/Cilastatin Kabi 500 mg/500 mg prašak za otopinu za infuzijuprašak za otopinu za infuziju · Fresenius Kabi d.o.o., Radnička cesta 37a, Zagreb, Hrvatska
- Recarbrio
- Miron 500 mg/500 mg prašak za otopinu za infuzijuprašak za otopinu za infuziju · Medochemie Ltd., Constatinoupoleos Str. 1-10, Limassol, Cipar
All medicines with Cilastatinnatrij
Every register, a page at a time. Strengths and packs are on each medicine’s page.
4 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Imipenem/Cilastatin Kabi 500 mg/500 mg prašak za otopinu za infuzijuCombination | Croatia | prašak za otopinu za infuziju | Marketed | Fresenius Kabi d.o.o., Radnička cesta 37a, Zagreb, Hrvatska | |
| Imipenem/cilastatin AptaPharma 500 mg/500 mg prašak za otopinu za infuzijuCombination | Croatia | prašak za otopinu za infuziju | Marketed | Apta Medica Internacional d.o.o., Likozarjeva ulica 6, Ljubljana, Slovenija | |
| RecarbrioCombination | Croatia | Marketed | |||
| Miron 500 mg/500 mg prašak za otopinu za infuzijuCombination | Croatia | prašak za otopinu za infuziju | Not marketed | Medochemie Ltd., Constatinoupoleos Str. 1-10, Limassol, Cipar |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Often combined with
Substances it shares a medicine with.
Sources
Compiled by Prognia from the public medicine registers of HALMED. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 1
- Medicines
- 4
- Companies
- 3



